Company
Repair Biotechnologies
We reverse atherosclerosis
Also known as Repair Biotechnologies, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Repair Biotechnologies, Inc.
- repairbiotechnologies.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Repair Biotechnologies develops the Cholesterol Degrading Platform, a safe approach to treating medical conditions that arise due to localized accumulations of excess cholesterol.
Funding snapshot
- Total raised
- $25.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.3M2025-11-14
Funding rounds
- Round, 2025
- $5.3M2025-11-14, SEC form D sold, 16 investors
- Round, 2024
- $6.2M2024-03-15, SEC form D sold, 7 investors
- Round, 2023
- $8.4M2023-06-02, SEC form D sold, 38 investors
- Round, 2021
- $200K2021-02-12, SEC form D sold, 2 investors
- Round, 2020
- $2.9M2020-08-25, SEC form D sold, 13 investors
- Round, 2019
- $2.1M2019-03-11, SEC form D sold, 15 investors
- Round, 2019
- $75K2019-01-14, SEC form D sold, 1 investor
- Round, 2018
- $450K2018-07-11, SEC form D sold, 6 investors
Products
- Other
- Cholesterol Degrading Platform
Loading relationship preview